In den Warenkorb
Bestellen Sie auch über:
![]() |
+33 (0)1 76 63 32 65 |
![]() |
+33 (0)1 74 18 08 22 |
GRO/CINC-2beta (C-Term) Antikörper
| Antigen | GRO/CINC-2beta |
| Epitope |
C-Term |
| Klonalität | Polyklonal |
| Wirt |
Kaninchen |
| Reaktivität |
Ratte (Rattus) |
| Applikation |
Western Blot (WB)
|
| Produktnummer | ABIN180138 |
| Menge | 100 µg |
| Preis | 324,00 € Zzgl. Versandkosten €40,00 und MWSt |
| Lieferung nach |
|
| Verfügbarkeit | Lieferung in 10 bis 15 Werktagen |
Produktbeschreibung
| Weitere Bezeichnung | GRO/CINC-2beta C-terminal |
| Immunogen | Synthetic peptide for C-Terminal of rat GRO/CINC-2À conjugating bovine thyroglobulin Purification: Affinity Purified with synthetic peptide |
| Isotyp | IgG (Passende Sekundärantikörper) |
| Beschreibung | Cytokine-induced neutrophil chemo attractant 1(CINC-1) was originally purified from media conditioned by IL-1 Àstimulated rat kidney epithelioid cells (NRK-52E). Amino acid sequence that encodes for rat CINC-1 was identified in 1989 by Watanabe's group at Toyama Medical and Pharmaceutical University. CINC-1 is a member of the alpha (CXC) subfamily of chemokines. Three additional rat CXC chemokines (CINC-2¿ , CINC-2À , CINC-3/MIP-2) have been identified. The protein sequence of CINC-1 is 63 - 67% identical to that of CINC-2¿ , CINC-2À , CINC-3/MIP-2. In addition, GRO¿ , GROÀ and GROÁ is sharing 68%, 71% and 69%, identity with CINC-1. This has been suggested that CINCs are the rat counterpart of human GROs. |
| Spezifität | Rat GRO/CINC-2 Àspecific. No crossreactivities with Rat GRO/CINC-1, Rat GRO/CINC-2¿ and Rat GRO/CINC-3 |
Anwendungen
| Applikationshinweise | This antibody can be used for western blotting in concentration of 2 - 5 ug/ml. |
| Reinigung | Antigen peptide |
| Buffer | Lyophilized product from 1% BSA in PBS containing 0.05%NaN3 . Reconstitution: 1 ml distilled water will be added to the product |
| Lagerung | Lyophilized product, 5 years at 2 8 C : Solution, 2 years at 20 C |
| Beschränkungen | Nur für Forschungszwecke einsetzbar |



